Lorenzo Sica

A Randomized Placebo Controlled Phase II Trial Evaluating Exemestane with or without Enzalutamide in Patients with Hormone Receptor–Positive Breast Cancer

Ian E. Krop, Vandana G. Abramson, Marco Colleoni et al. · Clinical Cancer Research · 2020 · 65 citations · Full text

Medicine, Oncology, Pharmacology +15

Phospho-TCTP as a therapeutic target of dihydroartemisinin for aggressive breast cancer cells

Maria Lucibello, Sara Adanti, Dario Dezi et al. · Oncotarget · 2015 · 62 citations · Full text

Medicine, Oncology, Pharmacology +15

Estimation of charging demand for electric vehicles by discrete choice models and numerical simulations: Application to a case study in Turin

Lorenzo Sica, Francesco Paolo Deflorio · Green Energy and Intelligent Transportation · 2023 · 45 citations · Full text

Planning, Infrastructure Planning, Urban Planning +17

Personalized Risk–Benefit Ratio Adaptation of Breast Cancer Care at the Epicenter of COVID-19 Outbreak

Giulia Viale, Luca Licata, Lorenzo Sica et al. · The Oncologist · 2020 · 37 citations · Full text

Medicine, Health Sciences, Oncology +13

Oncotype DX results increase concordance in adjuvant chemotherapy recommendations for early-stage breast cancer

Luca Licata, Giulia Viale, Mario Giuliano et al. · npj Breast Cancer · 2023 · 18 citations · Full text

Medicine, Oncology, Breast Oncology +6